Search Results - "MICHAELI, D"

Phase II Study of Anti–Gastrin-17 Antibodies, Raised to G17DT, in Advanced Pancreatic Cancer by BRETT, B. T, SMITH, S. C, CAPLIN, M. E, BOUVIER, C. V, MICHAELI, D, HOCHHAUSER, D, DAVIDSON, B. R, KURZAWINSKI, T. R, WATKINSON, A. F, VAN SOMEREN, N, POUNDER, R. E

“…The prognosis for advanced pancreatic cancer remains poor. Gastrin acts as a growth factor for pancreatic cancer. We describe the first study of the…”
Get full text

A phase II study of G17DT in gastric carcinoma by Gilliam, A.D, Watson, S.A, Henwood, M, McKenzie, A.J, Humphreys, J.E, Elder, J, Iftikhar, S.Y, Welch, N, Fielding, J, Broome, P, Michaeli, D

“…Purpose. G17DT is a gastrin immunogen, raising antibodies that blockade gastrin-stimulated growth. The aim of the study was to characterise antibody response…”
Get full text

Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer by SIMMS, M. S, SCHOLFIELD, D. P, JACOBS, E, MICHAELI, D, BROOME, P, HUMPHREYS, J. E, BISHOP, M. C

“…D17DT consists of the GnRH decapeptide linked to diphtheria toxoid. The aim of this pilot study was to assess the tolerance of D17DT and the production of…”
Get full text

Cost-effectiveness of icosapent ethyl for primary and secondary cardiovascular prevention in the UK by Michaeli, D T, Michaeli, J C, Boch, T, Michaeli, T

“…Abstract Background Treatment with icosapent ethyl reduces the risk of major adverse cardiovascular events by 25% in patients with hypertriglyceridemia…”
Get full text

Cost-effectiveness of cholesterol-lowering drugs for secondary cardiovascular prevention in the UK: ezetimibe, evolocumab, and alirocumab by Michaeli, D T, Michaeli, J C, Boch, T, Michaeli, T

“…Abstract Background Despite statin treatment, patients with elevated low-density lipoprotein cholesterol (LDL-C) levels remain at high risk for acute…”
Get full text

Coexpression of gastrin and gastrin receptors (CCK-B and ΔCCK-B) in gastrointestinal tumour cell lines by McWilliams, D F, Watson, S A, Crosbee, D M, Michaeli, D, Seth, R

“…Background—The peptide hormone gastrin is a recognised growth factor for gastrointestinal (GI) tumour cells. Carboxyamidated gastrins bind to the cell surface…”
Get full text

PCN251 An Econometric Analysis of Launch Determinants for MULTI-Indication Oncology Products by Michaeli, D., Mills, M., Kanavos, P.

Get full text

Regulation of cellulose synthesis in Acetobacter xylinum by cyclic diguanylic acid by Ross, P, Weinhouse, H, Aloni, Y, Michaeli, D, Weinberger-Ohana, P, Mayer, R, Braun, S, de Vroom, E, van der Marel, G. A, van Boom, J. H, Benziman, M

“…Cellulose is the most abundant renewable carbon resource on earth and is an indispensable raw material for the wood, paper, and textile industries. A model…”
Get full text

Phase I/II Study of G17-DT, an Anti-Gastrin Immunogen, in Advanced Colorectal Cancer by SMITH, Andrew M, JUSTIN, Timothy, MICHAELI, Dor, WATSON, Susan A

“…Gastrin is a growth factor for colorectal cancer, and therefore, anti-gastrin hormone therapy has a potential role in treatment of this disease. The gastrin…”
Get full text

The reemergence of sexually transmitted infections in Israel by Dan, Michael, Michaeli, D

Get full text

Comparison of predicted and measured contact pressures in normal and dysplastic hips by Michaeli, Daniel A., Murphy, Stephen B., Hipp, John A.

“…Hip dysplasia, a congenital and developmental deformity characterized by malorientation and a reduction of contact area between the femur and acetabulum, is…”
Get full text

Precision and accuracy of computed digital absorptiometry for assessment of bone density of the hand by BOUXSEIN, M. L, MICHAELI, D. A, PLASS, D. B, SCHICK, D. A, MELTON, M. E

“…Widespread osteoporosis testing and diagnosis are currently limited due to the high capital cost and reduced portability of many existing bone densitometry…”
Get full text

HTA4 Clinical Development and HTA Approval of MULTI-Indication Oncology Products: Evidence from Germany, France, England, Scotland, the US, Canada, and Australia by Mills, M., Michaeli, D., Miracolo, A., Kanavos, P.

Get full text

PNS73 Payer Perspectives on Pricing of MULTI-Indication Products by Mills, M., Miracolo, A., Michaeli, D., Kanavos, P.

Get full text

A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growth by Watson, S A, Morris, T M, Varro, A, Michaeli, D, Smith, A M

“…BACKGROUND Gastrin is a growth factor for established tumours. AIMS To investigate the therapeutic effect of antibodies, raised against the Gastrimmune…”
Get full text

Discontinuation of ventilation after brain stem death. Jews accept brain stem death by Michaeli, D

Get full text

Has smallpox finally been eradicated? by Michaeli, D

Get more information

Gastrimmune‐induced antigastrin‐17 antibodies inhibit acid secretion in a rat fistula model by Smith, A. M., Morris, T., Justin, T., Michaeli, D., Watson, S. A.

“…Background: Gastrimmune is an immunogenic form of gastrin. It raises in situ antibodies against two proliferative forms of gastrin: amidated and…”
Get full text

Effect of gastrin and anti-gastrin antibodies on proliferation of hepatocyte cell lines by CAPLIN, Martyn, KHAN, Kossar, GRIMES, Stephen, MICHAELI, Dov, SAVAGE, Kay, POUNDER, Roy, DHILLON, Amar

“…Gastrin (G-17) and its precursor glycine-extended gastrin (G-17-gly) have been shown to be trophic to some gastrointestinal tumors. This in vitro study…”
Get full text

Density predicts the activity-dependent failure load of proximal femora with defects by MICHAELI, D. A, INOUE, K, HAYES, W. C, HIPP, J. A

“…To determine whether the load-bearing capacity of human proximal femora with metastatic defects can be predicted from the bone mineral content. The bone…”
Get full text